معرفی
Lieven Annemans is a prominent Professor in Public Health Sciences at Vrije Universiteit Brussel (VUB), Brussels, Belgium. With an extensive research portfolio of 216 publications and an h-index of 38 reflecting over 7,000 citations, he has established himself as a leading authority in health economics and economic evaluation of healthcare interventions.
Dr. Annemans' research demonstrates exceptional specialization in health economics and cost-benefit analysis, with particular expertise in:
- Population-level healthcare evaluation
- End-of-life care economics
- HIV treatment optimization
- Environmental health economics
- Mental health intervention assessment
- Rehabilitation and return-to-work programs
His scholarly output reveals a methodological consistency in applying economic evaluation techniques across diverse healthcare domains. Recent work increasingly focuses on value-based healthcare approaches for chronic conditions including cancer, dementia, COPD, and HIV, while maintaining strong emphasis on Belgian healthcare system applications. The fingerprint analysis of his work shows dominant engagement with Cost-Benefit Analysis (100%), Costs and Cost Analysis (39%), and Belgium-specific healthcare research (37%).
Dr. Annemans has secured and led multiple significant research initiatives:
- TBM OPERA (2021-2025): Developing performance assessments for rehabilitation trajectories in failed back surgery patients
- FWOAL717 (2014-2017): Evaluating population-level end-of-life care quality and cost-effectiveness
- SOCOST (2013-2017): Analyzing social costs of legal and illegal drugs in Belgium
- KPMG Health Economics Chair (2013-2015): Establishing academic-industry collaboration in health economics
His academic service includes organizing and participating in major international conferences such as ISPOR, European Congress of Rheumatology, and HIV/tuberculosis modeling events. His research demonstrates tangible policy impact, with work referenced in policy documents and widely disseminated through academic channels including Mendeley and social media platforms.
